Caris & Co Initiates Coverage on Alberto-Culver (ACV) with an Above Average
More News related to ACV
- JPMorgan Selects 26 Small, Mid-Cap Stocks That Can Outperform
- David Moenning’s Daily State of the Markets: 11/03
- Citi Downgrades Alberto-Culver (ACV) to Hold
- Cramer Says Buy Alberto-Culver (ACV)
- Alberto-Culver (ACV) Reports Q4 EPS In-Line
More News related to New Coverage
- Citi Initiates Coverage on US Soft Drink Makers
- William Blair Initiates Coverage on Data Networking Stocks
- Caris Starts Coverage on Ariba (ARBA), Concur (CNQR), salesforce.com (CRM), Taleo (TLEO)
- Oppenheimer Initiates Coverage on ViroPharma (VPHM)
- Oppenheimer Initiates Coverage on Cadence Pharmaceuticals (CADX) with an Outperform
Caris & Co initiates coverage on Alberto-Culver (NYSE: ACV) with an Above Average. Price target $31.
Alberto-Culver Company (New Alberto-Culver), through its subsidiaries, operates two segments: Consumer Packaged Goods and Cederroth International.
Related Categories
New CoverageStocks Mentioned
+0.90Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
